Genomma Lab Internacional SAB de CV (LABB) Stock Statistics & Valuation Metrics

Genomma Lab Internacional SAB de CV has a market cap or net worth of MXN 15.14B. The enterprise value is MXN 17.56B.

Market Cap

MXN 15.14B

Enterprise Value

MXN 17.56B

Genomma Lab Internacional SAB de CV has 1,000,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

1,000,000,000

Owned by Insiders

―

Owned by Institutions

16.68%

Genomma Lab Internacional SAB de CV’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 12.78%.

Return on Equity (ROE)

0.14

Return on Assets (ROA)

0.07

Return on Invested Capital (ROIC)

12.78%

Return on Capital Employed (ROCE)

0.23

Revenue Per Employee

11.97M

Profits Per Employee

1.10M

Employee Count

1,465

Asset Turnover

0.74

Inventory Turnover

3.54

The current PE Ratio of Genomma Lab Internacional SAB de CV is 8.82. Genomma Lab Internacional SAB de CV’s PEG ratio is -2.26.

PE Ratio

8.82

PS Ratio

0.87

PB Ratio

1.25

Price to FCF

10.56

Price to Operating Cash Flow

9.20

PEG Ratio

-2.26

In the last 12 months, Genomma Lab Internacional SAB de CV had revenue of 17.54B and earned 1.61B in profits. Earnings per share was 1.65.

Revenue

17.54B

Gross Profit

11.02B

Operating Income

3.76B

Pretax Income

2.43B

Net Income

1.61B

EBITDA

3.61B

Earnings Per Share (EPS)

1.65

In the last 12 months, operating cash flow was 1.66B and capital expenditures -260.23M, giving a free cash flow of 1.40B billion.

Operating Cash Flow

1.66B

Free Cash Flow

1.40B

Free Cash Flow per Share

1.39

Genomma Lab Internacional SAB de CV pays an annual dividend of MXN 0.20, resulting in a dividend yield of 5.28%

Dividend Per Share

MXN 0.20

Dividend Yield

5.28%

Payout Ratio

49.60%

Free Cash Flow Yield

9.47%

Earnings Yield

11.12%

Beta

0.97

52-Week Price Change

-17.04%

50-Day Moving Average

13.24

200-Day Moving Average

15.13

Relative Strength Index (RSI)

65.08

Average Volume (3m)

3.62M

Genomma Lab Internacional SAB de CV upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 21, 2026

Next Earnings Date

Feb 24, 2027

Ex-Dividend Date

Jun 26, 2026

Genomma Lab Internacional SAB de CV as a current ratio of 1.77, with Debt / Equity ratio of 68.64%

Current Ratio

1.77

Quick Ratio

1.52

Debt to Market Cap

0.43

Net Debt to EBITDA

1.33

Interest Coverage Ratio

4.72

In the past 12 months, Genomma Lab Internacional SAB de CV has paid 826.24M in taxes.

Income Tax

826.24M

Effective Tax Rate

0.34

Genomma Lab Internacional SAB de CV EV to EBITDA ratio is 5.48, with an EV/FCF ratio of 14.36.

EV to Sales

1.18

EV to EBITDA

5.48

EV to Free Cash Flow

14.36

EV to Operating Cash Flow

12.11

Genomma Lab Internacional SAB de CV has MXN 2.74B in cash and marketable securities with MXN 8.06B in debt, giving a net cash position of -MXN 5.32B billion.

Cash & Marketable Securities

MXN 2.74B

Total Debt

MXN 8.06B

Net Cash

-MXN 5.32B

Net Cash Per Share

-MXN 5.32

Tangible Book Value Per Share

MXN 6.30

Gross margin is 62.61%, with operating margin of 19.91%, and net profit margin of 9.96%.

Gross Margin

62.61%

Operating Margin

19.91%

Pretax Margin

14.30%

Net Profit Margin

9.96%

EBITDA Margin

21.49%

EBIT Margin

19.35%

The average price target for Genomma Lab Internacional SAB de CV is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-5.98%

EPS Growth Forecast

-3.07%